{"name":"Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company","slug":"scorpion-therapeutics-a-wholly-owned-subsidiary-of-eli-lilly-and-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOVzJuWjU3M3J6QnFNZG5xeEZzNGQ2ZVlkWUFpNWJWSFZTZHRqMk1aU3NpdUhQWHAyU0pjYlZOV24wUEZ6V1FhYmtXODBHY2JHZlFVRmRFd3hXb3A5R2VMV05HOVZmWlFMcmppbjFTX3kyVGd1THRXQk1VX3YtYm5hdU51Z2hodGVqTEctZ0lrdlo4X0dtWDMtTWZEZlVOX1FMUXJUZ05TQjg?oc=5","date":"2026-02-10","type":"deal","source":"Boston.com","summary":"Eli Lilly snaps up Watertown biotech in $2.4 billion deal - Boston.com","headline":"Eli Lilly snaps up Watertown biotech in $2.4 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNamw3OGllNEVMejVzYi1Lc3JGUHFfMTFNWGJ6cmZYaVppNkh3SlE2TjdrdVlVUkhFRGtyX1g5a2pjQThadlctZVE0WWhIV2J4VDhSZXdrdDVweC03a1RSd2J2V1lzcnI4alFhMUhxbGZveGNIQURxUG9GTEMta05iM2xuX2FvNmxQX0xONQ?oc=5","date":"2026-02-09","type":"deal","source":"The Boston Globe","summary":"Eli Lilly to buy Watertown biotech Orna Therapeutics for $2.4 billion - The Boston Globe","headline":"Eli Lilly to buy Watertown biotech Orna Therapeutics for $2.4 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9EMzNyMDhRbjh1VHlqUWRGRURwLXA0bTFvdDM2Tk9YVDZfeDh2aFE3MUNCSFFRYXo0MWI1VW1VSUdISkRlQXMxcDRfbjJBZ0o5R1N2dFJTMktTOXVlaEVFQTlBbi1rcGxyUENEZjRkVjNiN21WNFF2ejZjc3g?oc=5","date":"2025-10-30","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Emerging Pharma: On the Industry’s Radar - DCAT Value Chain Insights","headline":"Emerging Pharma: On the Industry’s Radar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNSFBxazJSNU9yOTJuRl9naEhUV21Fekc2bzFoNkRncWx0R3BJNmtuRnpSVFZuOWtiNHB5Y18wV2dnaHEzeEtBVngxdnJGSWJadlJnYmc5X1FHWEhoampVbEVIV3o4SHlCSnZOY0NpVGVvQTJreDB2bDIwTW5Wems3OHJCREgwaTNBeFFWdEd1YjV2ZTdrZV90QjN4eUFiQWpYY1RZX3Q4S1ZQOEFFWE5zRE9n?oc=5","date":"2025-09-23","type":"pipeline","source":"Investing News Network","summary":"5 Biggest US Pharma Stocks - Investing News Network","headline":"5 Biggest US Pharma Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQc19xWlY3VFpvbkN4UmRoZ2hvbkM4VFFoQ0RmWl8yNUZEYW9zTnFyQlRMeWZ0dWdad3VVbWZramRzemF4enQyOUFhOWRVX0VXX2tZQzBnUXp4YS1oaTFHQ3IxTVpVcTJHemFSTUwtNUZOWGYwTzFjWEd0c21uWG1aSFVIR2F2RC1WYnEwNHp5UUdTeFJiQzJraFcydzZFdXZIeTExeXNB?oc=5","date":"2025-06-10","type":"deal","source":"BioPharma Dive","summary":"Scorpion, fresh off Lilly deal, spins out startup Antares - BioPharma Dive","headline":"Scorpion, fresh off Lilly deal, spins out startup Antares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQRXF4VXI5RXV4MHFxbXN6YzYxQy1pQ3BIWEFrY2dyWWtVSGxPYmY0dWlJbEJyT3JOSkR0b0M3ZU85VVcxWjN2NWpKSjVIZjJDc2xvYzNuZzJOV1NqRjZRVE16NVhQNWVBOHN5OS02Y2VzNXpUWW1LbHg2cFdDbnVlQU1nZGE4S19wdl9RLTU1VkoxX2FzdFpWb1VtVnY?oc=5","date":"2025-04-04","type":"pipeline","source":"BioSpace","summary":"Lilly Throws Sangamo a Lifeline With Pact Worth Potential $1.4B+ - BioSpace","headline":"Lilly Throws Sangamo a Lifeline With Pact Worth Potential $1.4B+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQMUNzQ3ZlM1R6a1lyakVQcHh1RG1xZ1Y5ZUdSMXJfOEtRRjJSZDFLRTJ4aHA5bWRHeEFLSkZobmkzWC1VM1ZBRXpwaGl1VFFFdm5ZMnJIM0xSdml0czY5NzVaR3Z2U3JJZFZ5LXV1TDlSUHpRT2l3SlpjSkdiTkJzakZJajFHRHd2aGtFd2FOTQ?oc=5","date":"2025-01-17","type":"regulatory","source":"Medical Marketing and Media","summary":"Rx Rundown: Johnson & Johnson, Eli Lilly, the FDA and more - Medical Marketing and Media","headline":"Rx Rundown: Johnson & Johnson, Eli Lilly, the FDA and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBsZUJvN0xmQUE0MXk0VWFUck5BTlhSQWNRRE96aUVwdndlWE8tcXFVbmI4aG01TkVia2ljcWlhekJkcG5CVnlCUVJrRUtpZ01XMWtoTkFQTnNUSWRsdzc1RlBQaXpHQjVCVVdsMnVDWjhGVkZRV1pqeUw2RWQ?oc=5","date":"2025-01-14","type":"pipeline","source":"The Pharma Letter","summary":"Lilly takes a nibble at Scorpion program - The Pharma Letter","headline":"Lilly takes a nibble at Scorpion program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQYm1QdmtkbWZhVkozSTlodUJ6SElrUGtWZTh2V1Q1WlpPakNadElOX2laTTBoa0F2LVo5YVhBMXBmbG1qZlpzbVBCUTZreEViTU13MUprdXpiZlVBVDBsMnJySDVmbGdiNV9PX0dXa2pMMlMxTlE4dktzbklub29uWTlLSG5tdXR0cFhBR0lRM3ZSS0RBenhJNnZaaXVoWWxaRHlwN0E2Y1BGUHRET3BGNFlvdzB6R1RDUzdLOQ?oc=5","date":"2025-01-13","type":"deal","source":"Eli Lilly","summary":"Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program | Eli Lilly and Company - Eli Lilly","headline":"Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program | Eli Lilly and Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE05TE9HcXJxR1M5UjBlNkpMVV9aSnN5Y00xaXpZRWJsRVo5d25PeFA3czRUNVl3TXlNMXptVGVST0d6UlNaNEtRSHFMakhiRkdMWjlTUllvRzhTU2RUTFFOWFNYZENhaFFWQ012Y0tTSQ?oc=5","date":"2025-01-13","type":"deal","source":"statnews.com","summary":"Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal - statnews.com","headline":"Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxORDhwVkVjd09rOUVMd21iMjJHc2xlQ0pmZ19SVzRHOU9GVFAxRlRhcUx6OXVSaWdfMlFDVUJFaDI1LXNjYnEtT1hRb2JKTHhmRllhMEl3MExLZ0ZwWHk1aTloSjFDTWlKcTlTREFydEE0UHBVYXBINmdsVVQwc3Y2eGFaSHlST3JL?oc=5","date":"2025-01-13","type":"deal","source":"pharmaphorum","summary":"Lilly nets Scorpion cancer drug in $2.5bn licensing deal - pharmaphorum","headline":"Lilly nets Scorpion cancer drug in $2.5bn licensing deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}